[Treatment of Candida infections in pregnancy with Miconazol ovules (author's transl)].
D000287:Administration, Topical; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004987:Ethers / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005865:Gestational Age; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*
D000935:Antifungal Agents; D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles; D009566:Nitrates
Ergebnis der Behandlung von Kandidainfektionen in der Schwangerschaft mit Miconazol-Ovula